WALGREENS BOOTS ALLIANCE INC's ticker is WBA and the CUSIP is 931427108. A total of 1,196 filers reported holding WALGREENS BOOTS ALLIANCE INC in Q2 2015. The put-call ratio across all filers is 1.47 and the average weighting 0.6%.
About WALGREENS BOOTS ALLIANCE INC
Walgreens Boots Alliance Inc. is a global pharmacy-led health and wellbeing company that operates in more than 25 countries. The company is headquartered in Deerfield, Illinois, and has a market capitalization of over $50 billion. Walgreens Boots Alliance operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale.
The Retail Pharmacy USA segment includes the Walgreens brand, which is the largest drugstore chain in the United States. The segment also includes the company's specialty pharmacy and retail healthcare clinics. The Retail Pharmacy International segment includes the Boots brand, which is a leading pharmacy-led health and beauty retailer in the United Kingdom and other countries. The Pharmaceutical Wholesale segment includes the company's wholesale and distribution businesses.
Walgreens Boots Alliance has been expanding its business through strategic partnerships and acquisitions. In 2018, the company acquired a 40% stake in Sinopharm Holding Guoda Drugstores Co. Ltd., which is one of the largest pharmacy chains in China. The company has also partnered with Kroger, one of the largest grocery store chains in the United States, to create a new retail concept that combines grocery and pharmacy services.
Despite the challenges posed by the COVID-19 pandemic, Walgreens Boots Alliance has continued to perform well. In the third quarter of 2021, the company reported a 12.1% increase in sales compared to the same period in the previous year. The company's strong performance can be attributed to its focus on providing essential healthcare services and products to customers around the world.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $22,240 | -21.9% | 1,000 | 0.0% | 0.00% | 0.0% |
Q2 2023 | $28,490 | -17.6% | 1,000 | 0.0% | 0.00% | -40.0% |
Q1 2023 | $34,580 | -7.4% | 1,000 | 0.0% | 0.01% | 0.0% |
Q4 2022 | $37,360 | +20.5% | 1,000 | 0.0% | 0.01% | 0.0% |
Q3 2022 | $31,000 | -18.4% | 1,000 | 0.0% | 0.01% | -16.7% |
Q2 2022 | $38,000 | -25.5% | 1,000 | -12.4% | 0.01% | -14.3% |
Q1 2022 | $51,000 | -15.0% | 1,142 | 0.0% | 0.01% | 0.0% |
Q4 2021 | $60,000 | +11.1% | 1,142 | 0.0% | 0.01% | 0.0% |
Q3 2021 | $54,000 | -33.3% | 1,142 | -25.9% | 0.01% | -36.4% |
Q2 2021 | $81,000 | -4.7% | 1,542 | 0.0% | 0.01% | -8.3% |
Q1 2021 | $85,000 | +51.8% | 1,542 | +10.1% | 0.01% | +33.3% |
Q4 2020 | $56,000 | +12.0% | 1,400 | 0.0% | 0.01% | -10.0% |
Q3 2020 | $50,000 | -15.3% | 1,400 | 0.0% | 0.01% | -23.1% |
Q2 2020 | $59,000 | -7.8% | 1,400 | 0.0% | 0.01% | -13.3% |
Q1 2020 | $64,000 | -22.9% | 1,400 | 0.0% | 0.02% | -6.2% |
Q4 2019 | $83,000 | +7.8% | 1,400 | 0.0% | 0.02% | 0.0% |
Q3 2019 | $77,000 | -11.5% | 1,400 | -12.5% | 0.02% | -11.1% |
Q2 2019 | $87,000 | -4.4% | 1,600 | +11.1% | 0.02% | -10.0% |
Q1 2019 | $91,000 | -5.2% | 1,440 | +2.9% | 0.02% | -9.1% |
Q4 2018 | $96,000 | +118.2% | 1,400 | +133.3% | 0.02% | +10.0% |
Q3 2018 | $44,000 | -47.6% | 600 | -57.1% | 0.02% | +11.1% |
Q2 2018 | $84,000 | -8.7% | 1,400 | 0.0% | 0.02% | -10.0% |
Q1 2018 | $92,000 | -9.8% | 1,400 | 0.0% | 0.02% | -4.8% |
Q4 2017 | $102,000 | -5.6% | 1,400 | 0.0% | 0.02% | -12.5% |
Q3 2017 | $108,000 | -1.8% | 1,400 | 0.0% | 0.02% | -4.0% |
Q2 2017 | $110,000 | -5.2% | 1,400 | 0.0% | 0.02% | -7.4% |
Q1 2017 | $116,000 | 0.0% | 1,400 | 0.0% | 0.03% | -3.6% |
Q4 2016 | $116,000 | -27.0% | 1,400 | -29.1% | 0.03% | +21.7% |
Q3 2016 | $159,000 | +35.9% | 1,974 | +41.0% | 0.02% | -30.3% |
Q2 2016 | $117,000 | -0.8% | 1,400 | 0.0% | 0.03% | -21.4% |
Q1 2016 | $118,000 | -0.8% | 1,400 | 0.0% | 0.04% | -8.7% |
Q4 2015 | $119,000 | +260.6% | 1,400 | +250.0% | 0.05% | +228.6% |
Q3 2015 | $33,000 | -2.9% | 400 | 0.0% | 0.01% | +7.7% |
Q2 2015 | $34,000 | 0.0% | 400 | 0.0% | 0.01% | 0.0% |
Q1 2015 | $34,000 | +13.3% | 400 | 0.0% | 0.01% | +8.3% |
Q4 2014 | $30,000 | – | 400 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Camber Capital Management LP | 5,200,000 | $115,648 | 3.81% |
Kiltearn Partners LLP | 1,939,900 | $43,143,376 | 3.41% |
EDGAR LOMAX CO/VA | 2,124,897 | $47,257,709 | 3.22% |
KLCM Advisors, Inc. | 769,120 | $17,105,232 | 3.22% |
AlphaCentric Advisors LLC | 225,000 | $5,004,000 | 2.84% |
Arkfeld Wealth Strategies, L.L.C. | 174,922 | $3,914,760 | 2.82% |
EUBEL BRADY & SUTTMAN ASSET MANAGEMENT INC | 783,076 | $17,416 | 2.54% |
IPG Investment Advisors LLC | 466,635 | $10,377,962 | 2.29% |
Cambridge Financial Group, Inc. | 184,574 | $4,104,926 | 2.24% |
Penn Mutual Asset Management | 91,000 | $2,023,840 | 1.90% |